TagsInflammatory

Tag: Inflammatory

Healthcare

Nordic Bioscience receives Letter of Support from the FDA for the CPa9-HNE biomarker in inflammatory bowel diseases

Ravindra Soni - November 11, 2024 0

Healthcare

FDA Approves IMULDOSA® (ustekinumab-srlf), Accord BioPharma's Biosimilar to STELARA® (ustekinumab), for the Treatment of Chronic Inflammatory Conditions

Ravindra Soni - October 14, 2024 0

Automobile

Triveni Bio Launches with $92 Million Series A Financing to Advance Genetics-Informed Precision Medicines for the Treatment of Immunological and Inflammatory (I&I) Disorders

Ravindra Soni - October 26, 2023 0

Most Read

HID joins FIDO Alliance Board, appoints Sean Dyon as Primary Delegate

October 14, 2026

Swan Realty launches Bodhi luxury residential project in Bengaluru’s Jayanagar

October 14, 2026

Tata Elxsi Q2 FY27 revenue rises 15% YoY to Rs 1,055.7 crore

October 14, 2026

CRIF-SIDBI report: Small business credit portfolio hits ₹50.9 lakh crore in June 2026

October 14, 2026

EDITOR PICKS

HID joins FIDO Alliance Board, appoints Sean Dyon as Primary Delegate

October 14, 2026

Swan Realty launches Bodhi luxury residential project in Bengaluru’s Jayanagar

October 14, 2026

Tata Elxsi Q2 FY27 revenue rises 15% YoY to Rs 1,055.7 crore

October 14, 2026

POPULAR POSTS

HID joins FIDO Alliance Board, appoints Sean Dyon as Primary Delegate

October 14, 2026

Swan Realty launches Bodhi luxury residential project in Bengaluru’s Jayanagar

October 14, 2026

Tata Elxsi Q2 FY27 revenue rises 15% YoY to Rs 1,055.7 crore

October 14, 2026

ABOUT US

BusinessFortnight (businessfortnight.com) is an Indian digital news and media platform that covers business, economy, banking, insurance, real estate, automobiles, aviation, and hospitality news

Contact us: editorbusinessfortnight(@)gmail.com

© BusinessFortnight.com. All Rights Reserved.